Stay updated on Ixazomib Combo in Relapsed/Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Record History shows a new revision entry (v3.3.2) and removal of the prior revision (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedFunding-related disclaimer was removed from the page. The prior notice about information possibly not being up to date is no longer displayed.SummaryDifference0.7%

- Check49 days agoChange DetectedA newer version entry appears in the Record History. The visible content and structure of the page are otherwise unchanged.SummaryDifference0.1%

- Check71 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference13%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check92 days agoChange DetectedPage updated to v3.0.2 with a new study-status entry dated Sept 8–9, 2025; older version and date were removed.SummaryDifference2%

Stay in the know with updates to Ixazomib Combo in Relapsed/Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.